AssayIndex
Reports by quarter

Reports submitted in 2025-Q4

Provenance classification became a required field. Median purity for the quarter is 99.12 % area, n=762. Read the 2025-Q4 state-of-the-index report →

762 records20 pagesmedian on this page 99.10 %updated 30 Jul 2026
0448813292.093.094.095.096.097.098.099.0100.092.00–92.25 %: n=092.25–92.50 %: n=092.50–92.75 %: n=092.75–93.00 %: n=093.00–93.25 %: n=093.25–93.50 %: n=093.50–93.75 %: n=093.75–94.00 %: n=094.00–94.25 %: n=094.25–94.50 %: n=094.50–94.75 %: n=094.75–95.00 %: n=095.00–95.25 %: n=095.25–95.50 %: n=095.50–95.75 %: n=195.75–96.00 %: n=296.00–96.25 %: n=396.25–96.50 %: n=196.50–96.75 %: n=196.75–97.00 %: n=597.00–97.25 %: n=1297.25–97.50 %: n=997.50–97.75 %: n=1697.75–98.00 %: n=3098.00–98.25 %: n=4598.25–98.50 %: n=5298.50–98.75 %: n=5398.75–99.00 %: n=8699.00–99.25 %: n=10999.25–99.50 %: n=8899.50–99.75 %: n=9399.75–100.00 %: n=156median 99.12 Purity (% area) Reports
Figure. Purity distribution for reports submitted in 2025-Q4. n=762, median 99.12 % area. Same fixed 92–100 % domain as every other purity histogram on this site, so quarters can be compared by eye.
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2026-041505GHRP-6QSCQSC-2508-K6231Janoshik2025-Q499.934.31—Buyer-sourced0PASS
AX-2026-042147SS-31 (Elamipretide)JEEPJEEP-2511-B8241Medutest2025-Q499.695.06107.4Buyer-sourced0PASS
AX-2026-041423TirzepatideQYBQYB-2507-T4628PeptideMeter2025-Q499.166.40—Buyer-sourced1MARGINAL
AX-2026-043623RetatrutidePPGPPG-2505-V7521PeptideMeter2025-Q498.565.27—Buyer-sourced0PASS
AX-2026-043452GonadorelinBCHBCH-2510-F4167Janoshik2025-Q498.254.7894.8Buyer-sourced0FAIL
AX-2026-042992PT-141 (Bremelanotide)MKMMKM-2509-B4043PeptideMeter2025-Q499.446.08—Buyer-sourced0PASS
AX-2026-042095GHRP-6HYBHYB-2511-R7904Medutest2025-Q499.935.41—Laboratory-retained1MARGINAL
AX-2026-041858AfamelanotideGSPGSP-2508-U3747Janoshik2025-Q499.555.8497.0Buyer-sourced0PASS
AX-2026-041799LiraglutideASYASY-{CAT}-2101Kestrel2025-Q499.933.97—Buyer-sourced0PASS
AX-2026-041523TirzepatideQSCQSC-2511-S6768VendorInvestigate2025-Q499.934.70—Buyer-sourced1MARGINAL
AX-2026-043610BPC-157PPGPPG-2511-A6658VendorInvestigate2025-Q499.762.30103.8Buyer-sourced0PASS
AX-2026-043129RetatrutideSSASSA-2510-E6613Medutest2025-Q497.414.69—Supplier-supplied2MARGINAL
AX-2026-041989GHRP-6AMBAMB-2506-D5337Janoshik2025-Q499.552.86—Buyer-sourced0PASS
AX-2026-041650PT-141 (Bremelanotide)FGPFGP-2505-K8288VendorInvestigate2025-Q498.783.84—Buyer-sourced0PASS
AX-2026-043084KPVKPKP-2509-N5703Janoshik2025-Q498.892.7396.0Buyer-sourced0FAIL
AX-2026-041800LiraglutideASYASY-{CAT}-2101Janoshik2025-Q499.934.0799.8Buyer-sourced0PASS
AX-2026-042691TB-500ERPERP-2511-L9306Medutest2025-Q499.375.2495.9Buyer-sourced1MARGINAL
AX-2026-043485MK-677 (Ibutamoren mesylate)BCHBCH-2510-P5124PeptideMeter2025-Q497.955.9989.0Buyer-sourced1FAIL
AX-2026-041773Enclomiphene citrateASYASY-{CAT}-1806Janoshik2025-Q499.883.59—Buyer-sourced1FAIL
AX-2026-043463BPC-157BCHBCH-2508-H4066Medutest2025-Q498.503.28—Buyer-sourced0PASS
AX-2026-043342N-Acetyl Semax AmideWXTWXT-2505-J2528Janoshik2025-Q498.405.53—Buyer-sourced0FAIL
AX-2026-042995PT-141 (Bremelanotide)MKMMKM-2509-B4043VendorInvestigate2025-Q499.006.3596.7Buyer-sourced1MARGINAL
AX-2026-042692TB-500ERPERP-2511-L9306Janoshik2025-Q498.765.22—Laboratory-retained1MARGINAL
AX-2026-041277TirzepatideWWBWWB-2506-T2732Nordanalyt2025-Q499.104.05107.3Laboratory-retained0PASS
AX-2026-043481SemaglutideBCHBCH-2505-Y5388Janoshik2025-Q497.906.0398.7Buyer-sourced1MARGINAL
AX-2026-042993PT-141 (Bremelanotide)MKMMKM-2509-B4043Janoshik2025-Q499.415.25—Laboratory-retained0PASS
AX-2026-041413RetatrutideQYBQYB-2507-R4727Janoshik2025-Q498.354.68—Buyer-sourced0PASS
AX-2026-043075TirzepatideKPKP-2506-B5255PeptideMeter2025-Q498.183.57—Laboratory-retained0PASS
AX-2026-041798PramlintideASYASY-{CAT}-2288VendorInvestigate2025-Q499.104.5398.7Laboratory-retained0PASS
AX-2026-041416RetatrutideQYBQYB-2507-R4727Kestrel2025-Q498.434.58102.7Buyer-sourced0PASS
AX-2026-043435TB-500WXTWXT-2507-J4054Medutest2025-Q497.833.03102.6Buyer-sourced0FAIL
AX-2026-042385Melanotan IIHomopeptideHOMO-2505-N4086Nordanalyt2025-Q498.852.78—Buyer-sourced0PASS
AX-2026-042293SemaglutideTFCTFC-2507-U1178Janoshik2025-Q499.294.06101.8Buyer-sourced1MARGINAL
AX-2026-042106N-Acetyl Semax AmideJEEPJEEP-2507-U8215PeptideMeter2025-Q499.838.7395.5Buyer-sourced1MARGINAL
AX-2026-043148SemaglutideSSASSA-2509-J7377PeptideMeter2025-Q497.816.24—Buyer-sourced0PASS
AX-2026-042818LiraglutideGGPepsGGPE-2505-W2368Janoshik2025-Q498.837.56—Buyer-sourced1MARGINAL
AX-2026-041772OxytocinASYASY-{CAT}-1898VendorInvestigate2025-Q499.283.31101.2Buyer-sourced0PASS
AX-2026-043343N-Acetyl Semax AmideWXTWXT-2505-J2528Medutest2025-Q498.305.11—Buyer-sourced0FAIL
AX-2026-042994PT-141 (Bremelanotide)MKMMKM-2509-B4043Medutest2025-Q499.375.38105.6Buyer-sourced0PASS
AX-2026-041282CJC-1295 with DACWWBWWB-2509-J2816Kestrel2025-Q499.623.39102.8Buyer-sourced0PASS